Immediate Impact

2 by Nobel laureates 2 from Science/Nature 57 standout
Sub-graph 1 of 24

Citing Papers

Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options
2024 Standout
Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma
2023 Standout
2 intermediate papers

Works of C. Mormont being referenced

A phase II trial of dacomitinib, an oral pan-human EGF receptor (HER) inhibitor, as first-line treatment in recurrent and/or metastatic squamous-cell carcinoma of the head and neck
2012
Effects of Angiotensin-Converting Enzyme Inhibition in Low-Risk Patients Early After Coronary Artery Bypass Surgery
2007

Author Peers

Author Last Decade Papers Cites
C. Mormont 106 97 46 97 13 318
Masayuki Yao 126 60 43 33 11 354
Benjamin J. Lieblong 56 24 26 36 12 303
Eva Schnabel 18 60 41 65 11 353
Frederick G. Berlinger 42 38 74 10 15 356
Ede Birtalan 62 39 34 153 12 315
S. F. Smith 17 70 86 16 23 326
J Schmerber 82 273 30 24 25 345
Mette Christoffersen 30 19 95 50 16 331
Xiaohong Luo 77 34 40 16 20 308
John Wiswell 50 36 56 17 18 342

All Works

Loading papers...

Rankless by CCL
2026